What are the most appropriate treatments for patients with Polycystic Ovary Syndrome (PCO) who desire fertility?
- Well ASRM and ESHRE had a consensus meeting last year and here is the abstract (most important points highlighted in bold by me):
Consensus on infertility treatment related to polycystic ovary syndrome.
The treatment of infertile women with polycystic ovary syndrome (PCOS) is surrounded by many controversies. On the basis of the currently available evidence, a group of experts reached a consensus regarding the therapeutic challenges raised in these women. Before any intervention is initiated, preconceptional counseling should be provided emphasizing the importance of lifestyle, especially weight reduction and exercise in overweight women, smoking, and alcohol consumption. The recommended first-line treatment for ovulation induction remains the anti-estrogen clomiphene citrate (CC). Recommended second-line intervention, should CC fail to result in pregnancy, is either exogenous gonadotropins or laparoscopic ovarian surgery (LOS). The use of exogenous gonadotropins is associated with increased chances for multiple pregnancy, and, therefore, intense monitoring of ovarian response is required. Laparoscopic ovarian surgery alone is usually effective in less than 50% of women, and additional ovulation induction medication is required under those circumstances. Overall, ovulation induction (representing the CC-gonadotropin paradigm) is reported to be highly effective with a cumulative singleton live-birth rate of 72%. Recommended third-line treatment is in vitro fertilization (IVF). More patient-tailored approaches should be developed for ovulation induction based on initial screening characteristics of women with PCOS. Such approaches may result in deviation from the above mentioned first-line, second-line, or third-line ovulation strategies in well-defined subsets of patients. Metformin use in PCOS should be restricted to women with glucose intolerance. Based on recent data available in the literature, the routine use of this drug in ovulation induction is not recommended. Insufficient evidence is currently available to recommend the clinical use of aromatase inhibitors for routine ovulation induction. Even singleton pregnancies in PCOS are associated with increased health risk for both the mother and the fetus.
- Source : Fertility And Sterility via MEDLINE
Contact Dr. Vidali
Click on any topic for articles!
ivf clomid diminished ovarian reserve amh day 3 fsh ivf explanation sperm clomifene habitual abortion infertility male infertility miscarriage "ivf success rates" Age and fertility alternative medicine fsh ivf failure pcos progesterone "fertility and the environment" Age Antimullerian Hormone IVF success rates Religion acupuncture amh levels autism embryo transfer ene femara fertility fertility test in vitro fertilization iui iui success rates ivf baby ivf birth defects nutrition polycystic ovaries stress and fertility "IVF cost" Clinic Statistics DHEA Ectopic Pregnancy Fertile period Tubal Disease basal body temperature birth defects blastocyst caffeine clomid success rates cystic fibrosis early menopause endometrial thickness environment failed ivf fertility risk factors fetal demise fetal heart rate fetal ultrasound genetics glucophage hMG icsi birth defects immunology insemination ivf success rate lifestyle and luteal phase metformin ohss ovulation induction philosopical issues in medicine pregnancy rates premature ovarian failure reproductive immunology serophene sperm donation sperm donor tdi